Evidence map›Paper›PMID 33842699›Full record

ArticleHeliyon2021

Synthesis, structural characterization, and DFT studies of anti-cancer drug

S N Chandana, Fares Hezam Al-Ostoot, Yasser Hussein Eissa Mohammed, Tareq N Al-Ramadneh, P Akhileshwari, Shaukath Ara Khanum, M A Sridhar, B N Lakshminarayana

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Design, synthesis, anti-breast cancer andFuture medicinal chemistry · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S N ChandanaDepartment of Engineering Physics, Adichunchanagiri Institute of Technology, Jyothinagara, Chikkamamagaluru 577102, Karnataka, India.
Fares Hezam Al-OstootDepartment of Chemistry Yuvaraja's College, University of Mysore, Mysore, Karnataka, India.
Yasser Hussein Eissa MohammedDepartment of Chemistry Yuvaraja's College, University of Mysore, Mysore, Karnataka, India.
Tareq N Al-RamadnehDepartment of Basic Science, Biology Unit, Deanship of Preparatory Year and Supporting Studies, Imam Abdul Rahman Binn Faisal University, Saudi Arabia.
P AkhileshwariDepartment of Studies in Physics, Manasagangotri, University of Mysore, Mysuru 570006, Karnataka, India.
Shaukath Ara KhanumDepartment of Chemistry Yuvaraja's College, University of Mysore, Mysore, Karnataka, India.
M A SridharDepartment of Studies in Physics, Manasagangotri, University of Mysore, Mysuru 570006, Karnataka, India.
B N LakshminarayanaDepartment of Engineering Physics, Adichunchanagiri Institute of Technology, Jyothinagara, Chikkamamagaluru 577102, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug design is an integrated and developing system that portends an era of a novel and safe tailored drugs. It involves studying the effects of biologically active synthetic, semi-synthetic, and natural compounds based on molecular interactions in terms of molecular structure with activated functional groups or its unique physicochemical properties involved. The title compound,

Indexed as

3D-interaction energiesDFTDocking analysisHirshfeld surfaceXRD

Identifiers

PMID33842699
PMCPMC8020429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.